Compare HTHT & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTHT | KLTOW |
|---|---|---|
| Founded | 2005 | N/A |
| Country | China | United States |
| Employees | N/A | 3 |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | N/A |
| IPO Year | 2010 | 2022 |
| Metric | HTHT | KLTOW |
|---|---|---|
| Price | $48.49 | $0.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $47.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | N/A |
| Earning Date | 11-17-2025 | N/A |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | ★ 7.24 | N/A |
| EPS | ★ 1.76 | N/A |
| Revenue | ★ $3,484,239,807.00 | N/A |
| Revenue This Year | $7.12 | N/A |
| Revenue Next Year | $6.64 | N/A |
| P/E Ratio | $27.59 | ★ N/A |
| Revenue Growth | ★ 5.77 | N/A |
| 52 Week Low | $30.13 | N/A |
| 52 Week High | $49.49 | N/A |
| Indicator | HTHT | KLTOW |
|---|---|---|
| Relative Strength Index (RSI) | 63.51 | 50.43 |
| Support Level | $48.06 | $0.10 |
| Resistance Level | $49.49 | $0.15 |
| Average True Range (ATR) | 1.04 | 0.02 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 70.84 | 70.60 |
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.